The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price [Seeking Alpha]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Seeking Alpha
EW's TAVR business has reaccelerated from early in 2025, supported by new clinical data and guideline changes, and TMTT could double revenue share by 2030. Competitive risks from MDT, BSX, and ABT persist, but EW's pipeline and recent FDA approvals underpin credible long-term growth targets. I see margin expansion and free cash flow leverage ahead, yet I would await a pullback before considering new positions at these levels. asikkk/iStock via Getty Images High valuations don't necessarily preclude further market-beating gains, but they do tend to drive more volatility, and I think Edwards Lifesciences ( EW ) is a case in point. While this company continues to log impressive growth for its size, the Street still This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my ow
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing [Yahoo! Finance]Yahoo! Finance
- Edwards calls off JenaValve buyout after court halts deal [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Edwards Lifesciences (NYSE:EW) was given a new $90.00 price target on by analysts at Robert W. Baird.MarketBeat
- Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
EW
Earnings
- 10/30/25 - Beat
EW
Sec Filings
- 1/12/26 - Form 8-K
- 1/9/26 - Form 4
- 1/6/26 - Form 4
- EW's page on the SEC website